News & Updates
Filter by Specialty:
Mutations affect efficacy of avelumab in advanced endometrial cancer
Avelumab immunotherapy may perform poorly in advanced endometrial cancer (EC) patients with TP53 mutation but has positive effects in those with mutations of PTEN and ARID1A, suggest the results of the MITO END-3 trial.
Mutations affect efficacy of avelumab in advanced endometrial cancer
09 Jul 2024
IBS diagnosis tied to lower all-cause, cancer mortality
A diagnosis of irritable bowel syndrome (IBS), a common functional gastrointestinal disorder, appears to contribute to a reduced risk of death, but this association weakens over time, a study has shown.
IBS diagnosis tied to lower all-cause, cancer mortality
08 Jul 2024
Nadofaragene firadenovec promotes bladder preservation in BCG-unresponsive NMIBC
Nadofaragene firadenovec-vncg helps preserve the bladder in patients with bacillus Calmette-Guérin (BCG)-unresponsive nonmuscle-invasive bladder cancer (NMIBC) at 5 years, with an acceptable safety profile, as shown in a phase III trial.
Nadofaragene firadenovec promotes bladder preservation in BCG-unresponsive NMIBC
05 Jul 2024
Bladder cancer survivors who do not smoke enjoy better life quality
Among patients with bladder cancer (BC), those who do not smoke appear to have better longitudinal health-related quality of life (HRQoL) measures, particularly in the domains of physical function, emotional function, and fatigue, according to a recent study.
